3 insider filings
Gilbert Lynn Marks, insider filing for ANTX
Show all 3
- 4Insider filing for ANTX
- 4Insider filing for ANTX
- 4Insider filing for ANTX
Gilbert Lynn Marks, reporting
ANTX
AN2 Therapeutics, Inc. SEC filings
Every EDGAR filing for AN2 Therapeutics, Inc. (ANTX), newest first, with AI summaries and stories.
- Ticker
- ANTX
- CIK
- 1880438
- Latest filing
- 5d
Next: earnings expected ~Nov 12 · 10-Q expected ~Nov 12 (deadline Nov 16)
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE4AN2 Therapeutics, Inc.ANTXLIVE ROUTINE4AN2 Therapeutics, Inc.ANTXLIVE Cameron C. Trenor III, insider filing for ANTX
Cameron C. Trenor III, reporting
ROUTINES-8AN2 Therapeutics, Inc.ANTXLIVE ROUTINE4AN2 Therapeutics, Inc.ANTXLIVE Robin Shane Readnour, insider filing for ANTX
Robin Shane Readnour, reporting
ROUTINE4AN2 Therapeutics, Inc.ANTXLIVE Robin Shane Readnour, insider filing for ANTX
Robin Shane Readnour, reporting
ROUTINE4AN2 Therapeutics, Inc.ANTXLIVE Sarah Joanne Williams, insider filing for ANTX
Sarah Joanne Williams, reporting
ROUTINE4AN2 Therapeutics, Inc.ANTXLIVE Margaret M FitzPatrick, insider filing for ANTX
Margaret M FitzPatrick, reporting
ROUTINE3AN2 Therapeutics, Inc.ANTXLIVE Cameron C. Trenor III, new insider at ANTX
Cameron C. Trenor III, reporting
ROUTINE4AN2 Therapeutics, Inc.ANTXLIVE Robin Shane Readnour, insider filing for ANTX
Robin Shane Readnour, reporting
ROUTINE144AN2 Therapeutics, Inc.ANTXLIVE Robin Shane Readnour, planned sale of ANTX shares
Robin Shane Readnour, reporting
ROUTINE4AN2 Therapeutics, Inc.ANTXLIVE Joseph S Zakrzewski, insider filing for ANTX
Joseph S Zakrzewski, reporting
NOTABLE10-QAN2 Therapeutics, Inc.ANTXLIVE ROUTINE8-KAN2 Therapeutics, Inc.ANTXLIVE ROUTINE4AN2 Therapeutics, Inc.ANTXLIVE 3 insider filings
Kabeer Aziz, insider filing for ANTX
Show all 3
- 4Insider filing for ANTX
- 4Insider filing for ANTX
- 4Insider filing for ANTX
Kabeer Aziz, reporting
ROUTINE4AN2 Therapeutics, Inc.ANTXLIVE Joshua M Eizen, insider filing for ANTX
Joshua M Eizen, reporting
ROUTINE8-KAN2 Therapeutics, Inc.ANTXLIVE ROUTINE4AN2 Therapeutics, Inc.ANTXLIVE Sarah Joanne Williams, insider filing for ANTX
Sarah Joanne Williams, reporting
ROUTINESCHEDULE 13G/AAN2 Therapeutics, Inc.ANTXLIVE Ownership stake disclosure by Almitas Capital LLC (amended)
Almitas Capital LLC, filed by
ROUTINE8-KAN2 Therapeutics, Inc.ANTXLIVE NOTABLE10-QAN2 Therapeutics, Inc.ANTXLIVE ROUTINEARSAN2 Therapeutics, Inc.ANTXLIVE ROUTINEDEF 14AAN2 Therapeutics, Inc.ANTXLIVE ROUTINEDEFA14AAN2 Therapeutics, Inc.ANTXLIVE ROUTINEEFFECTAN2 Therapeutics, Inc.ANTXLIVE ROUTINE424B3AN2 Therapeutics, Inc.ANTXLIVE 2 structured-note prospectuses
Securities offering
Show all 2
- 424B3Securities offering
- 424B5Securities offering
ROUTINE4AN2 Therapeutics, Inc.ANTXLIVE 3 insider filings
Kabeer Aziz, insider filing for ANTX
Show all 3
- 4Insider filing for ANTX
- 4Insider filing for ANTX
- 4Insider filing for ANTX
Kabeer Aziz, reporting
ROUTINES-3AN2 Therapeutics, Inc.ANTXLIVE ROUTINE8-KAN2 Therapeutics, Inc.ANTXLIVE ROUTINEDAN2 Therapeutics, Inc.ANTXLIVE ROUTINE4AN2 Therapeutics, Inc.ANTXLIVE 12 insider filings
Lucy Day, insider filing for ANTX
Show all 12
- 4Insider filing for ANTX
- 4Insider filing for ANTX
- 4Insider filing for ANTX
- 4Insider filing for ANTX
- 4Insider filing for ANTX
- 4Insider filing for ANTX
- 4Insider filing for ANTX
- 4Insider filing for ANTX
- 4Insider filing for ANTX
- 4Insider filing for ANTX
- 4Insider filing for ANTX
- 4Insider filing for ANTX
Lucy Day, reporting
ROUTINE8-KAN2 Therapeutics, Inc.ANTXLIVE ROUTINES-8AN2 Therapeutics, Inc.ANTXLIVE